InspireMD Inc expected to post a loss of 63 cents a share - Earnings Preview

InspireMD

06/08/2021 13:18

* InspireMD Inc  NSPR.OQ   NSPR.O  is expected to show a rise in
quarterly revenue when it reports results on August 10. 
* The Tel Aviv-yafo, Israel-based company is expected to report 
 a 251.4% increase in revenue to $1.1 million from $313 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for InspireMD Inc is for a
loss of 63 cents per share. For the same quarter last year, the
company reported a loss of $3.00 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for InspireMD Inc
is $16.5​, about 76.7% above​ its last closing price
of $3.84. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.60       -0.60      -0.53     Beat    11.7
 Dec. 31 2020  -0.90       -0.97      -1.20     Missed  -23.1
 Sep. 30 2020  -1.20       -2.70      -0.90     Beat    66.7​
 Jun. 30 2020  -5.25       -5.25      -3.00     Beat    42.9
 Mar.          -9.45​      -9.45      -6.45     Beat    31.7​
 31​ 2020​                                              
 Dec. 31 2019  -8.55       -8.55      -8.55     Met     0​
 Sep. 30 2019  -20.25      -20.25     -18.90    Beat    6.7
 Jun. 30 2019              -30.00     -23.85    Beat    20.5
 This summary was machine generated August 6 at 12:18 GMT.  All
figures in US dollars unless otherwise stated